| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/2004 | US6677164 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds |
| 01/13/2004 | US6677155 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 01/13/2004 | US6677152 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 01/13/2004 | US6677148 Pesticidal proteins |
| 01/13/2004 | US6677144 Isolated nucleic acid molecules encoding human pyruvate dehydrogenase E1-alpha subunit proteins |
| 01/13/2004 | US6677138 Production of a multimeric protein by cell fusion method |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6677135 Ret ligand (RetL) for stimulating neutral and renal growth |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6677126 Antibody for human translational regulator |
| 01/13/2004 | US6677125 Diagnosing spongiform encephalopathies; obtain sample containing preferential protein, incubate with antibody, detect formation of bound complex |
| 01/13/2004 | US6677119 Methods of detecting a colon cancer cell |
| 01/13/2004 | US6677118 Incubating under stringent hybridization conditions with nucleic acid probe |
| 01/13/2004 | US6677117 Inducing cell differentiation |
| 01/13/2004 | US6677116 Methods for treating cancer by modulating β-catenin mediated gene expression |
| 01/13/2004 | US6676985 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |
| 01/13/2004 | US6676948 Haemophilus adherence and penetration proteins |
| 01/13/2004 | US6676946 Dendrimeric polylysine having bonded epitopes; cancer immuno-therapy |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676944 Vaccine containing a peroxiredoxin and/or a β-tubulin |
| 01/13/2004 | US6676942 Undergoes polymerase chain reaction with primers prospa1-a4 but not prospa1-a2 |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/13/2004 | US6676940 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676936 Chimeric and/or growth-restricted flaviviruses |
| 01/13/2004 | US6676935 Transfection target cells; genetic engineering |
| 01/13/2004 | CA2132533C Protein purification |
| 01/13/2004 | CA2000498C Osteogenic factors |
| 01/08/2004 | WO2004003567A1 Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a) |
| 01/08/2004 | WO2004003563A2 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 01/08/2004 | WO2004003553A1 Methods for identifying novel transcription inhibitors |
| 01/08/2004 | WO2004003227A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 01/08/2004 | WO2004003207A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | WO2004003203A1 Human cervical cancer 5 protooncogene and protein encoded therein |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003199A1 Novel method of acquiring nucleic acid or gene |
| 01/08/2004 | WO2004003198A1 Method of examining allergic disease and drug for treating the same |
| 01/08/2004 | WO2004003197A1 Yeast-origin promoter and vector and expression system using the same |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003192A1 Human receptor tyrosine kinase mertk |
| 01/08/2004 | WO2004003176A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | WO2004003172A2 Esm-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same |
| 01/08/2004 | WO2004003170A2 Agents capable of inhibiting ras and uses thereof |
| 01/08/2004 | WO2004003165A2 Novel polynucleotide and polypeptide sequences and uses thereof |
| 01/08/2004 | WO2004003163A2 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 01/08/2004 | WO2004003161A2 Immunogenic mycoplasma hyopneumoniae polypeptides |
| 01/08/2004 | WO2004003160A2 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 01/08/2004 | WO2004003159A2 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders |
| 01/08/2004 | WO2004003158A2 Methods and compositions for modulating and detecting wisp activity |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003156A2 Il-21 as a regulator of immunoglobin production |
| 01/08/2004 | WO2004003153A2 Live replicating spumavirus vector |
| 01/08/2004 | WO2004003152A2 Sos1 inhibitors |
| 01/08/2004 | WO2004003151A2 Protein production methods and modified cells for use therein |
| 01/08/2004 | WO2004003150A2 Modulators and modulation of the interacton between rgm and neogenin |
| 01/08/2004 | WO2004003149A2 Cngh0005 polypeptides, antibodies, compositions, methods and uses |
| 01/08/2004 | WO2004003148A2 Genes encoding proteins with pesticidal activity |
| 01/08/2004 | WO2004003147A2 Cngh0004 polypeptides, antibodies, compositions, methods and uses |
| 01/08/2004 | WO2004003145A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | WO2004003143A2 Viruses and virus-like particles for multiple antigen and target display |
| 01/08/2004 | WO2004003141A2 A protein that interacts with lipids and methods for treating hyperlipidemia |
| 01/08/2004 | WO2004003140A2 Cytokine receptor zcytor17 multimers |
| 01/08/2004 | WO2004003133A1 Pain signaling molecules |
| 01/08/2004 | WO2004003018A1 Nuclear hormone receptor |
| 01/08/2004 | WO2004003017A1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 01/08/2004 | WO2004003016A2 Marked peptides having affinity for a phospholipid and uses |
| 01/08/2004 | WO2004003015A2 Peptides having affinity for a phospholipid and uses |
| 01/08/2004 | WO2004003014A2 Gene for increased somatic recombination |
| 01/08/2004 | WO2004003013A1 Gene for increased somatic recombination |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004003011A2 Nuclear hormone receptor |
| 01/08/2004 | WO2004003010A2 Nuclear hormone receptor ligano-binding domain containing protein |
| 01/08/2004 | WO2004003009A2 Francisella tularensis immunogenic proteins and dna encoding these |
| 01/08/2004 | WO2004003008A2 Peptides for inducing apoptosis in tumor cells |
| 01/08/2004 | WO2004003006A2 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 01/08/2004 | WO2004002532A1 Mkk7 activation inhibitor |
| 01/08/2004 | WO2004002517A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002516A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002515A1 Diagnostics/preventives/remedies for respiratory diseases |
| 01/08/2004 | WO2004002514A1 Preventives/remedies for cancer |
| 01/08/2004 | WO2004002513A2 Proteins involved in the regulation of energy homeostasis |
| 01/08/2004 | WO2004002512A1 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 01/08/2004 | WO2004002510A1 Novel use of lipopeptide preparations |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002418A2 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | WO2004002415A2 Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| 01/08/2004 | WO2004002253A1 Necktie wearing-device |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2004002216A2 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 01/08/2004 | WO2003095484A3 Polypeptides increasing p53 expression |
| 01/08/2004 | WO2003093455A3 Adenovirus vectors for immunotherapy |
| 01/08/2004 | WO2003093315A3 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 01/08/2004 | WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase |
| 01/08/2004 | WO2003090666A3 Glucocorticoid receptor protein crystals |
| 01/08/2004 | WO2003089469A3 Cation channel proteins |
| 01/08/2004 | WO2003087139A3 Treatment of gastroparesis |
| 01/08/2004 | WO2003080839A3 Antigen fragments for the diagnosis of toxoplasma gondii |
| 01/08/2004 | WO2003080665A3 Antibody that binds to a dimer of a prion protein for the treatment of tse infection |